pounds,11 or R,ꢀ-unsaturated compounds12 with hydrazines and
cycloaddition reactions of fluoroalkenes with diazocom-
pounds.13 In contrast, synthetic strategies toward fluorinated
amino- or hydroxypyrazoles have not been studied intensively,
although various nonfluorinated amino- and hydroxypyrazoles
are often associated with pronounced bioactivities. Indeed, the
established activities of Zaleplon, Sildenafil, and Allopurinol
have led to a revival of interest in aminopyrazoles.14 Despite
their promising bioactivities, only a few fluorinated 3-amino-
and 3-hydroxypyrazoles have been synthesized.15
In a first synthetic strategy toward 3-amino-4-fluoropy-
razoles, the direct electrophilic fluorination of the com-
mercially available 3-amino-5-methyl-1H-pyrazole 1 was
investigated. In contrast to the efficient direct chlorination,
bromination, and iodination of 3-aminopyrazole 1,16 the
direct fluorination using Selectfluor or xenon(II) fluoride did
not afford the corresponding 4-fluoropyrazole, even when
the free 3-amino group was protected as an aldimine derived
from benzaldehyde. The obtained complex reaction mixtures
confirm the low yields reported in the literature for the direct
fluorination of pyrazoles. Surprisingly, pyrazole 1 was
entirely converted to a mixture of 5-amino-3-methyl-1-
phenylsulfonyl-1H-pyrazole 217 and 3-amino-5-methyl-1-
phenylsulfonyl-1H-pyrazole 3 in a 9:1 ratio upon reaction
with N-fluorobenzenesulfonimide (NFSI) (Scheme 1). This
The most common method to prepare 3-aminopyrazoles
involves the condensation of ꢀ-ketonitriles with hydrazines.19
The corresponding monofluorinated ꢀ-ketonitriles have not
been used before in analogous condensation reactions, which
is probably due to their difficult synthesis.20 Also in our
hands, various strategies to synthesize 7 via electrophilic or
nucleophilic monofluorination failed. Fortunately, a good
synthetic pathway toward benzoylfluoroacetonitrile 7 in gram
quantities was developed by the reaction of the anion of
(diphenylphosphinoyl)fluoroacetonitrile 6, prepared in situ
from fluoroacetonitrile 4 and diphenylphosphinyl chloride
5,21 with benzoyl chloride followed by aqueous workup
(Scheme 2). The synthesis of the desired 3-amino-4-
Scheme 2. Synthesis of 3-Amino- and
3-Hydroxy-4-fluoropyrazoles 9 and 10
Scheme 1. Reaction of Pyrazole 1 with NFSI
fluoropyrazole 9 was subsequently carried out by heating
the obtained benzoylfluoroacetonitrile 7 at reflux temperature
with hydrazine hydrate in isopropanol during 30 min. Despite
reaction can be compared to the sulfonylation of 3-aminopy-
razoles using sulfonyl chlorides.18 Because of the observed
difficulties in the direct fluorination of aminopyrazoles, new
strategies were evaluated to synthesize these interesting
targets.
(14) (a) Elmaati, T. M. A.; El-Taweel, F. M. J. Heterocycl. Chem. 2004,
41, 109. (b) Pochat, F. Tetrahedron Lett. 1979, 32, 2991. (c) Moreno-Manas,
M.; Sebastian, R. M.; Vallribera, A.; Carini, F. Synthesis 1999, 157. (d)
Tang, J.; Shewchuk, L. M.; Sato, H.; Hasegawa, M.; Washio, Y.; Nishigaki,
N. Bioorg. Med. Chem. Lett. 2003, 13, 2985. (e) Teng, M.; Zhu, J.; Johnson,
M. D.; Chen, P.; Kornmann, J.; Chen, E.; Blasina, A.; Register, J.; Anderes,
K.; Rogers, C.; Deng, Y.; Ninkovic, S.; Grant, S.; Hu, Q.; Lundgren, K.;
Peng, Z.; Kania, R. S. J. Med. Chem. 2007, 50, 5253.
(10) Katoch-Rouse, R.; Horti, A. G. J. Labelled Compd. Radiopharm.
2003, 46, 93.
(15) (a) Selby, T. P.; Stevenson, T. M. PCT Int. Appl., WO 2000071536,
2000; Chem. Abstr. 2000, 134, 17497. (b) Ohata, S.; Kato, K.; Toriyabe,
K.; Ito, Y.; Hamaguchi, R.; Nakano, Y. PCT Int. Appl., WO 2009051245,
2009; Chem. Abstr. 2009, 150, 472709. (c) Kuze, S.; Koboshi, S.; Myaoka,
K. Jpn. Kokai Tokkyo Koho JP 08166663, 1996; Chem. Abstr. 1996, 125,
208340. (d) Ishii, F.; Wada, H. Jpn. Kokai Tokkyo Koho JP 62195659,
1987; Chem. Abstr. 1987, 109, 231008.
(11) For recent examples, see: (a) Sloop, J. C.; Bumgardner, C. L. J.
Fluorine Chem. 2002, 118, 135. (b) Katoch-Rouse, R.; Pavlova, O. A.;
Caulder, T.; Hoffman, A. F.; Mukhin, A. G.; Horti, A. G. J. Med. Chem.
2003, 46, 642. (c) Guillou, S.; Bonhomme, F. J.; Janin, Y. Synthesis 2008,
3504.
(12) (a) Bouillon, J.-P.; Didier, B.; Dondy, B.; Doussot, P.; Plantier-
Royon, R.; Portella, C. Eur. J. Org. Chem. 2001, 187. (b) Dondy, B.;
Doussot, P.; Portella, C. Tetrahedron Lett. 1994, 35, 409. (c) Chanteau, F.;
Plantier-Royon, R.; Portella, C. Synlett 2004, 512. (d) Ishihara, T.; Okada,
Y.; Kuroboshi, M.; Shinozaki, T.; Ando, T. Chem. Lett. 1988, 819. (e)
Funabiki, K.; Ohtsuki, T.; Ishihara, T.; Yamanaka, H. Chem. Lett. 1995,
239. (f) Zhang, Q.; Lu, L. Tetrahedron Lett. 2000, 41, 8545.
(13) (a) Hanamoto, T.; Koga, Y.; Kawanami, T.; Furuno, H.; Inanaga,
J. Angew. Chem., Int. Ed. 2004, 43, 3582. (b) Hanamoto, T.; Iwamoto, Y.;
Yamada, K.; Anno, R. J. Fluorine Chem. 2007, 128, 1126. (c) Hanamoto,
T.; Koga, Y.; Kido, E.; Kawanami, T.; Furuno, H.; Inanaga, J. Chem.
Commun. 2005, 2041. (d) Hanamoto, T.; Suetake, T.; Koga, Y.; Kawanami,
T.; Furuno, H.; Inanaga, J. Tetrahedron 2007, 63, 5062. (e) Blackwell, G. B.;
Haszeldine, R. N.; Taylor, D. R. J. Chem. Soc., Perkin Trans. 1 1982, 2207.
(16) (a) Blake, A. J.; Clarke, D.; Mares, R. W.; McNab, H. Org. Biomol.
Chem. 2003, 1, 4268. (b) Dziomko, V. M.; Berestevich, B. K. Khim
Geterotsikl. Soedin. 1978, 382. (c) Krasovskiy, A. L.; Hartulyari, A. S.;
Nenajdenko, V. G.; Balenkova, E. S. Synthesis 2002, 2133.
(17) Ramiz, M. M. M.; Elghandour, A. H. H.; Ibrahim, M. K. A.;
Mansour, O. A. E. R. Arch. Pharm. 1989, 322, 557.
(18) Ege, G.; Franz, H. J. Heterocycl. Chem. 1984, 21, 689.
(19) Reddy, G. J.; Latha, D.; Srinivasa Rao, K. Org. Prep. Proced. Int.
2004, 36, 494.
(20) (a) Peng, W.; Shreeve, J. M. Tetrahedron Lett. 2005, 46, 4905. (b)
Chambers, R. D.; Hutchinson, J. J. Fluorine Chem. 1998, 92, 45. For a
synthesis of 7 using perchloryl fluoride, see: (c) Ridge, D. N.; William
Hanifin, J.; Harten, L. A.; Johnson, B. D.; Menschik, J.; Nicolau, G.;
Sloboda, A. E.; Watts, D. E. J. Med. Chem. 1979, 22, 1385.
Org. Lett., Vol. 12, No. 20, 2010
4649